A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Clinical trial NCT03105336 · COMPLETED
Trial details
- NCT number
- NCT03105336
- Sponsor
- Kite, A Gilead Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-06
- Primary completion
- 2024-12-20
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.